查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618547

肺癌手術市場：按手術設備、手術程序和最終用戶分類 - 全球預測 2025-2030 年

Lung Cancer Surgery Market by Surgical Devices (Endo Surgical Equipment, Monitoring & Visualizing Systems, Surgical Instruments), Surgical Procedures (Minimally Invasive Surgeries, Thoracotomy), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年肺癌手術市場價值為56.9億美元，預計到2024年將達到60.1億美元，預計複合年成長率為5.88%，到2030年達到85億美元。

肺癌手術的範圍和定義包括旨在從肺部去除癌組織的各種外科手術。這個領域包括切除術、楔形切除術、切除術和切除術等手術，且胸腔鏡手術、電視輔助胸腔鏡手術（VATS）和機器人手術等微創方法都很重要。肺癌手術的必要性源自於非小細胞肺癌（NSCLC）的根治性治療通常輔以化療和放射線治療。它的用途涵蓋治癒性和姑息性治療，透過手術緩解晚期癌症的症狀。典型的最終使用者包括醫院、專科診所和癌症治療中心。根據市場洞察，肺癌發病率上升、手術技術進步、微創手術的採用增加以及支持性醫療保健政策推動了成長。然而，挑戰包括手術成本上升、與手術併發症相關的風險以及對熟練外科醫生的需求。潛在的商機在於新興市場、不斷發展的醫療基礎設施以及人工智慧和手術機器人等技術創新。建議包括擴大微創手術、加強術後護理以及重點開發具有成本效益的手術解決方案。限制來自於需要改進患者選擇和更好地整合多種治療方法。我們也面臨早期診斷的挑戰。創新機會包括個人化手術方法、利用基因組資料改善結果、提高手術器械精度的進步。市場競爭激烈，重點是技術進步和協作研究以最佳化治療效果，而以患者為中心的方法和成本控制則推動成長。

主要市場統計
基準年[2023] 56.9億美元
預計年份 [2024] 60.1億美元
預測年份 [2030] 85億美元
複合年成長率（%） 5.88%

市場動態：快速發展的肺癌手術市場的關鍵市場洞察

供需的動態交互作用正在改變肺癌手術市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 吸菸增加導致肺癌發生率增加
    • 越來越重視癌症的早期診斷和早期治療
    • 更多採用微創技術
  • 市場限制因素
    • 肺癌診治費用高
  • 市場機會
    • 肺癌治療技術不斷進步
    • 癌症治療的報銷政策和政府支持的可用性
  • 市場挑戰
    • 缺乏訓練有素的專業人員

波特五力：開拓肺癌手術市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肺癌手術市場的外部影響

外部宏觀環境因素對肺癌手術市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解肺癌手術市場的競爭狀況

肺癌手術市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣肺癌手術市場供應商的績效評估

FPNV 定位矩陣是評估肺癌手術市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製肺癌手術市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對肺癌手術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 肺癌發生率上升和吸菸趨勢增加
      • 癌症的早期診斷和治療變得越來越重要
      • 更多採用微創技術
    • 抑制因素
      • 肺癌診療費用高昂
    • 機會
      • 肺癌治療技術進展
      • 癌症治療的報銷政策和政府支持的可用性
    • 任務
      • 缺乏訓練有素的專業人員
  • 市場區隔分析
    • 手術設備：監測和可視化系統的技術進步可改善複雜的肺癌手術過程
    • 手術：肺癌微創手術因其減輕疼痛和恢復更快的優點而越來越受到青睞。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章肺癌手術市場手術設備

  • 末端手術設備
  • 監控及視覺化系統
    • 相機和影片支持
    • 具有光學視野的內視鏡套管針
  • 手術器械
    • 手用儀器
      • 夾鉗
      • 刀具
      • 電梯
      • 鉗子
      • 牽開器
      • 肋骨剪刀
      • 剪刀
      • 訂書機
      • 套管針
    • 電動手術設備

第7章依手術方式分類的肺癌手術市場

  • 微創手術
  • 開胸手術
    • 切除術
    • 肺切除術
    • 部分切除術
    • 袖狀切除術

第8章肺癌手術市場：依最終用戶分類

  • 醫院
  • 專業癌症治療中心

第9章北美及南美肺癌手術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太肺癌手術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲肺癌手術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 諾華收購 Mariana Oncology 增強癌症治療能力
    • Harmonic 臨床試驗的擴展，東亞非吸菸者非小細胞肺癌治療的新領域
    • 開創性的移植計畫為第四期肺癌患者帶來新的生命
  • 戰略分析和建議

公司名單

  • Accuray Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics Inc.
  • Baxter Healthcare Corporation
  • FusionKraft Surgical Instruments
  • Henry Schein, Inc.
  • Intuitive Surgical Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ GmbH
  • Key Surgical LLC by STERIS plc
  • KLS Martin Group
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Richard Wolf GmbH
  • Scanlan International Inc.
  • Siemens Healthineers AG
  • Sontec Instruments Inc.
  • Teleflex Incorporated
  • TROKAMED GmbH
  • Wexler Surgical Inc.
Product Code: MRR-501246436957

The Lung Cancer Surgery Market was valued at USD 5.69 billion in 2023, expected to reach USD 6.01 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 8.50 billion by 2030.

The scope and definition of lung cancer surgery encompass various surgical procedures aimed at removing cancerous tissues from the lungs, which is critical in managing early-stage lung cancers and improving survival rates. This field involves techniques such as lobectomy, wedge resection, segmentectomy, and pneumonectomy, with thoracotomy and minimally invasive approaches like video-assisted thoracoscopic surgery (VATS) and robotic surgery being crucial. The necessity of lung cancer surgery arises from its role as a curative treatment for non-small cell lung cancer (NSCLC) in localized stages, often complemented by chemotherapy or radiotherapy. Its application extends to both curative and palliative care, where surgery alleviates symptoms in advanced cancer stages. The main end-users include hospitals, specialty clinics, and cancer care centers. Market insights suggest growth is driven by rising lung cancer prevalence, advancements in surgical techniques, increasing adoption of minimally invasive surgeries, and supportive healthcare policies. However, challenges include high surgical costs, risks related to surgical complications, and the need for highly skilled surgeons. Potential opportunities lie in emerging markets, growing healthcare infrastructure, and technological innovations like AI and robotics in surgery. Recommendations include focusing on expanding minimally invasive procedures, enhancing post-surgical care, and developing cost-effective surgical solutions. Limitations stem from the need for improved patient selection and better integration of multimodal therapies. The market also faces the challenge of early diagnosis, which is vital for surgical eligibility. Innovation opportunities exist in personalized surgery approaches, leveraging genomic data to improve outcomes, and advancements in surgical tools enhancing precision. The nature of the lung cancer surgery market is competitive, with an increasing emphasis on technological advancements and collaborations to optimize treatment efficacy while focusing on patient-centric approaches and cost management to drive growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.69 billion
Estimated Year [2024] USD 6.01 billion
Forecast Year [2030] USD 8.50 billion
CAGR (%) 5.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lung Cancer Surgery Market

The Lung Cancer Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of lung cancer coupled with growing trend of smoking tobacco
    • Increasing emphasis on early diagnosis & treatment of cancers
    • Growing adoption of minimally invasive techniques
  • Market Restraints
    • High cost of lung cancer diagnosis & treatments
  • Market Opportunities
    • Rising technological advancements in lung cancer treatment
    • Availability of reimbursements policies and government support for cancer treatments
  • Market Challenges
    • Shortage of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Lung Cancer Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lung Cancer Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lung Cancer Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lung Cancer Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lung Cancer Surgery Market

A detailed market share analysis in the Lung Cancer Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lung Cancer Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lung Cancer Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lung Cancer Surgery Market

A strategic analysis of the Lung Cancer Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Surgery Market, highlighting leading vendors and their innovative profiles. These include Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., Baxter Healthcare Corporation, FusionKraft Surgical Instruments, Henry Schein, Inc., Intuitive Surgical Inc., Johnson & Johnson Services, Inc., KARL STORZ GmbH, Key Surgical LLC by STERIS plc, KLS Martin Group, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scanlan International Inc., Siemens Healthineers AG, Sontec Instruments Inc., Teleflex Incorporated, TROKAMED GmbH, and Wexler Surgical Inc..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgical Devices, market is studied across Endo Surgical Equipment, Monitoring & Visualizing Systems, and Surgical Instruments. The Monitoring & Visualizing Systems is further studied across Cameras & Video Support and Endoscopic Trocars with Optical Views. The Surgical Instruments is further studied across Hand Instruments and Powered Surgical Equipment. The Hand Instruments is further studied across Clamps, Cutters, Elevators, Foreceps, Retractors, Rib Shears, Scissors, Staplers, and Trocar.
  • Based on Surgical Procedures, market is studied across Minimally Invasive Surgeries and Thoracotomy. The Thoracotomy is further studied across Lobectomy, Pneumenectomy, Segmentectomy, and Sleeve Resection.
  • Based on End-user, market is studied across Hospitals and Specialized Cancer Treatment Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of lung cancer coupled with growing trend of smoking tobacco
      • 5.1.1.2. Increasing emphasis on early diagnosis & treatment of cancers
      • 5.1.1.3. Growing adoption of minimally invasive techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of lung cancer diagnosis & treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancements in lung cancer treatment
      • 5.1.3.2. Availability of reimbursements policies and government support for cancer treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
    • 5.2.2. Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Lung Cancer Surgery Market, by Surgical Devices

  • 6.1. Introduction
  • 6.2. Endo Surgical Equipment
  • 6.3. Monitoring & Visualizing Systems
    • 6.3.1. Cameras & Video Support
    • 6.3.2. Endoscopic Trocars with Optical Views
  • 6.4. Surgical Instruments
    • 6.4.1. Hand Instruments
      • 6.4.1.1. Clamps
      • 6.4.1.2. Cutters
      • 6.4.1.3. Elevators
      • 6.4.1.4. Foreceps
      • 6.4.1.5. Retractors
      • 6.4.1.6. Rib Shears
      • 6.4.1.7. Scissors
      • 6.4.1.8. Staplers
      • 6.4.1.9. Trocar
    • 6.4.2. Powered Surgical Equipment

7. Lung Cancer Surgery Market, by Surgical Procedures

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgeries
  • 7.3. Thoracotomy
    • 7.3.1. Lobectomy
    • 7.3.2. Pneumenectomy
    • 7.3.3. Segmentectomy
    • 7.3.4. Sleeve Resection

8. Lung Cancer Surgery Market, by End-user

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialized Cancer Treatment Centers

9. Americas Lung Cancer Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Lung Cancer Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Lung Cancer Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology
    • 12.3.2. Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia
    • 12.3.3. Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Inc.
  • 2. Ackermann Instrumente GmbH
  • 3. AngioDynamics Inc.
  • 4. Baxter Healthcare Corporation
  • 5. FusionKraft Surgical Instruments
  • 6. Henry Schein, Inc.
  • 7. Intuitive Surgical Inc.
  • 8. Johnson & Johnson Services, Inc.
  • 9. KARL STORZ GmbH
  • 10. Key Surgical LLC by STERIS plc
  • 11. KLS Martin Group
  • 12. Koninklijke Philips N.V.
  • 13. Medtronic PLC
  • 14. Olympus Corporation
  • 15. Richard Wolf GmbH
  • 16. Scanlan International Inc.
  • 17. Siemens Healthineers AG
  • 18. Sontec Instruments Inc.
  • 19. Teleflex Incorporated
  • 20. TROKAMED GmbH
  • 21. Wexler Surgical Inc.

LIST OF FIGURES

  • FIGURE 1. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. LUNG CANCER SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LUNG CANCER SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LUNG CANCER SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDO SURGICAL EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CAMERAS & VIDEO SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CLAMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CUTTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELEVATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY FORECEPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RIB SHEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY TROCAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED SURGICAL EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PNEUMENECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SEGMENTECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SLEEVE RESECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SPECIALIZED CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 329. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 330. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX,